20 Oct 2021 --- Middle-market private equity firm Gryphon Investors is acquiring Metagenics, a nutraceutical company that develops and manufactures lifestyle medicines. The acquisition will bolster Metagenics’ portfolio of global nutritional solutions recommended by healthcare practitioners.
